Danish pharma big Novo Nordisk teased promising early-stage trial outcomes of its experimental weight loss tablet amycretin, sending the corporate’s stock surging.Ozempic and Trulicity are both of those used to deal with sort 2 diabetic issues. Equally medications even have protective consequences on the guts and kidneys.How it really works is us